Researchers performed a randomized clinical trial to compare resting-state functional magnetic resonance imaging connectivity-guided intermittent theta burst stimulation vs. repetitive transcranial magnetic stimulation for therapy-resistant depression.
Rentschler Biopharma announces largest single investment at its headquarters in Germany – Biotech Investments
EQS-News: Rentschler Biopharma SE / Key word(s): Strategic Company Decision/Expansion Rentschler Biopharma announces largest single investment at its headquarters in Germany 24.10.2024 / 07:30 CET/CEST